BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32336638)

  • 1. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
    Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
    J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.
    Urbani C; Russo D; Raggi F; Lombardi M; Sardella C; Scattina I; Lupi I; Manetti L; Tomisti L; Marcocci C; Martino E; Bogazzi F
    J Endocrinol Invest; 2014 Oct; 37(10):949-55. PubMed ID: 24996936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIP mutation in pituitary adenomas in the 18th century and today.
    Chahal HS; Stals K; Unterländer M; Balding DJ; Thomas MG; Kumar AV; Besser GM; Atkinson AB; Morrison PJ; Howlett TA; Levy MJ; Orme SM; Akker SA; Abel RL; Grossman AB; Burger J; Ellard S; Korbonits M
    N Engl J Med; 2011 Jan; 364(1):43-50. PubMed ID: 21208107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
    Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
    Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
    Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
    Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic features of a large kindred with a germline AIP variant.
    Dal J; Nielsen EH; Klose M; Feldt-Rasmussen U; Andersen M; Vang S; Korbonits M; Jørgensen JOL
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):146-153. PubMed ID: 32324286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
    Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
    Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
    PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
    Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
    Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
    Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.